Ross DM, Babon JJ, Tvorogov D, Thomas D. Persistence of myelofibrosis treated with ruxolitinib: biology and clinical implications. Haematologica 2021;106(5):1244-1253; https://doi.org/10.3324/haematol.2020.262691.